Atorvastatin favorably modulates proinflammatory cytokine profile in patients following deep vein thrombosis

Thrombosis Research

Volumn 132, Issue 1, 2013, Pages

  Zółciński, Marek ^a   Cieśla Dul, Mariola ^a   Potaczek, Daniel P ^a   Undas, Anetta ^a,b  

^a Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Inflammation; Statins; Venous thromboembolism

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ADULT; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DEEP VEIN THROMBOSIS; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; TREATMENT WITHDRAWAL;

INFLAMMATION; STATINS; VENOUS THROMBOEMBOLISM;

C-REACTIVE PROTEIN; CYTOKINES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; INTERLEUKINS; P-SELECTIN; PYRROLES; VENOUS THROMBOEMBOLISM;

EID: 84881316581     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.04.026     Document Type: Article

References (40)

1. J.A. Heit The epidemiology of venous thromboembolism in the community Arterioscler Thromb Vasc Biol 28 2008 370 372
2. J. Wu, M.J. Stevenson, J.M. Brown, E.A. Grunz, T.L. Strawn, and W.P. Fay C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance Arterioscler Thromb Vasc Biol 28 2008 698 704 (Pubitemid 351651347)
3. C. Chen, B. Nan, P. Lin, and Q. Yao C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells Thromb Res 122 2008 125 133 (Pubitemid 351618333)
4. J.A. Chirinos, G.A. Heresi, H. Velasquez, W. Jy, J.J. Jimenez, and E. Ahn Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism J Am Coll Cardiol 45 2005 1467 1471 (Pubitemid 40615620)
5. B. van Aken, M. den Heijer, G. Bos, S. van Deventer, and P. Reitsma Recurrent venous thrombosis and markers of inflammation Thromb Haemost 83 2000 536 539 (Pubitemid 30201126)
6. E.M. Hald, S.K. Brækkan, E.B. Mathiesen, I. Njølstad, T. Wilsgaard, and J. Brox High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study Haematologica 96 2011 1189 1194
7. E.M. Roumen-Klappe, M.C. Janssen, J. Van Rossum, S. Holewijn, M.M. Van Bokhoven, and K. Kaasjager Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study J Thromb Haemost 7 2009 582 587
8. Y.I. Tichelaar, H.J. Kluin-Nelemans, and K. Meijer Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review Thromb Haemost 107 2012 827 837
9. R. Glynn, E. Danielson, F. Fonseca, J. Genest, A.J. Gotto, and J. Kastelein A randomized trial of rosuvastatin in the prevention of venous thromboembolism N Engl J Med 360 2009 1851 1861
10. K. Rahimi, N. Bhala, P. Kamphuisen, J. Emberson, S. Biere-Rafi, and V. Krane Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials PLoS Med 9 2012 e1001310
11. M.A. Albert, E. Danielson, N. Rifai, P.M. Ridker, and P. Investigators Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study JAMA 286 2001 64 70 (Pubitemid 32606333)
12. J. Musial, A. Undas, P. Gajewski, M. Jankowski, W. Sydor, and A. Szczeklik Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia Int J Cardiol 77 2001 247 253 (Pubitemid 32155911)
13. P. Marschang, G.J. Friedrich, H. Ditlbacher, A. Stoeger, D.Z. Nedden, and R. Kirchmair Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease Int J Cardiol 106 2006 183 190 (Pubitemid 41728936)
14. C. Hernández, G. Francisco, A. Ciudin, P. Chacón, B. Montoro, and G. Llaverias Effect of atorvastatin on lipoprotein (a) and interleukin-10: a randomized placebo-controlled trial Diabetes Metab 37 2011 124 130
15. D.J. Mulder, P.L. van Haelst, M.H. Wobbes, R.O. Gans, F. Zijlstra, and J.F. May The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress Cardiovasc Drugs Ther 21 2007 91 97 (Pubitemid 46834905)
16. A. Undas, K.E. Brummel-Ziedins, and K.G. Mann Statins and blood coagulation Arterioscler Thromb Vasc Biol 25 2005 287 294 (Pubitemid 40189147)
17. M. Zolcinski, M. Ciesla-Dul, and A. Undas Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism Thromb Haemost 107 2012 1180 1182
18. M. Galli, W. Ageno, A. Squizzato, F. Dentali, E. Manfredi, and L. Steidl Residual venous obstruction in patients with a single episode of deep vein thrombosis and in patients with recurrent deep vein thrombosis Thromb Haemost 94 2005 93 95 (Pubitemid 40974711)
19. S.R. Kahn How I, treat postthrombotic syndrome Blood 114 2009 4624 4631
20. A. Undas, M. Celinska-Lowenhoff, T.B. Domagala, T. Iwaniec, J. Dropinski, and T. Lowenhoff Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia Thromb Haemost 94 2005 193 199 (Pubitemid 40974724)
21. A. Undas, A. Machnik, D.P. Potaczek, E. Wypasek, K. Zmudka, and W. Tracz Ezetimibe combined with simvastatin compared with simvastatin alone results in a greater suppression of oxidative stress and enhanced fibrinolysis in patients after acute coronary events J Cardiovasc Pharmacol 58 2011 167 172
22. P. Saha, J. Humphries, B. Modarai, K. Mattock, M. Waltham, and C.E. Evans Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions Arterioscler Thromb Vasc Biol 31 2011 506 512
23. E. Ascer, M.C. Bertolami, M.L. Venturinelli, V. Buccheri, J. Souza, and J.C. Nicolau Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients Atherosclerosis 177 2004 161 166 (Pubitemid 39361151)
24. J. Jawień Atherosclerosis in 2012: what is new? Pol Arch Med Wewn 122 2012 170 173
25. V. Cavalca, F. Veglia, I. Squellerio, G. Marenzi, F. Minardi, and M. De Metrio Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age and gender Eur J Clin Invest 39 2009 267 272
26. I.B. McInnes, G.G. Illei, C.L. Danning, C.H. Yarboro, M. Crane, and T. Kuroiwa IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis J Immunol 167 2001 4075 4082 (Pubitemid 32910855)
27. S. Ben-Hadj-Khalifa, P. Nguyen, T. Mahjoub, and N. Hézard Anticoagulant properties of the anti-inflammatory cytokine IL-10 in a factor Xa-activated human monocyte model Eur Cytokine Netw 23 2012 87 92
28. J.S. Millar, B. Ky, M.L. Wolfe, L. Pruscino, A. Baer, and D.J. Rader Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levels Clin Transl Sci 3 2010 140 146
29. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., and J.J. Kastelein Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
30. P. Kostakou, G. Kolovou, K. Anagnostopoulou, T. Theodoridis, V. Galea, and C. Mihas Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia Arch Cardiovasc Dis 103 2010 26 32
31. A.O. Spiel, J.C. Gilbert, and B. von Jilma Willebrand factor in cardiovascular disease: focus on acute coronary syndromes Circulation 117 2008 1449 1459 (Pubitemid 351501497)
32. Q. Zhou, and J.K. Liao Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy Curr Pharm Des 15 2009 467 478
33. K.B. Deatrick, M. Elfline, N. Baker, C.E. Luke, S. Blackburn, and C. Stabler Postthrombotic vein wall remodeling: preliminary observations J Vasc Surg 53 2011 139 146
34. B.M. Mazetto, F.L. Orsi, A. Barnabé, E.V. De Paula, M.C. Flores-Nascimento, and J.M. Annichino-Bizzacchi Increased ADAMTS13 activity in patients with venous thromboembolism Thromb Res 130 2012 889 893
35. T.R. Meier, D.D. Myers, S.K. Wrobleski, P.J. Zajkowski, A.E. Hawley, and P.W. Bedard Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation Thromb Haemost 99 2008 343 351 (Pubitemid 351230965)
36. B.M. Wojcik, S.K. Wrobleski, A.E. Hawley, T.W. Wakefield, D.D. Myers, and J.A. Diaz Interleukin-6: a potential target for post-thrombotic syndrome Ann Vasc Surg 25 2011 229 239
37. B. Cosmi, C. Legnani, M. Cini, G. Guazzaloca, and G. Palareti D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis Thromb Haemost 105 2011 837 845
38. J. Polgar, J. Matuskova, and D.D. Wagner The P-selectin, tissue factor, coagulation triad J Thromb Haemost 3 2005 1590 1596 (Pubitemid 41716543)
39. F. Violi, C. Calvieri, D. Ferro, and P. Pignatelli Statins as antithrombotic drugs Circulation 127 2013 251 257
40. M.C. Kleinegris, A.J. Ten Cate-Hoek, and H. Ten Cate Coagulation and the vessel wall in thrombosis and atherosclerosis Pol Arch Med Wewn 122 2012 557 566